183 related articles for article (PubMed ID: 14678288)
1. N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states.
Schultz M; Faber J; Kistorp C; Jarløv A; Pedersen F; Wiinberg N; Hildebrandt P
Clin Endocrinol (Oxf); 2004 Jan; 60(1):54-9. PubMed ID: 14678288
[TBL] [Abstract][Full Text] [Related]
2. Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism.
Ozmen B; Ozmen D; Parildar Z; Mutaf I; Bayindir O
Endocr Res; 2007; 32(1-2):1-8. PubMed ID: 18271501
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of NT-pro-brain natriuretic peptide in patients with overt and subclinical hyperthyroidism and hypothyroidism.
Pakuła D; Marek B; Kajdaniuk D; Krysiak R; Kos-Kudła B; Pakuła P; Gatnar A; Borgiel-Marek H; Nowak M; Siemińska L; Głogowska-Szeląg J; Ostrowska Z
Endokrynol Pol; 2011; 62(6):523-8. PubMed ID: 22144219
[TBL] [Abstract][Full Text] [Related]
4. Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states.
Christ-Crain M; Morgenthaler NG; Meier C; Müller C; Nussbaumer C; Bergmann A; Staub JJ; Müller B
Swiss Med Wkly; 2005 Sep; 135(37-38):549-54. PubMed ID: 16333765
[TBL] [Abstract][Full Text] [Related]
5. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R
Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of brain natriuretic peptide levels in hyperthyroidism and hypothyroidism.
Ertugrul DT; Gursoy A; Sahin M; Unal AD; Pamuk B; Berberoglu Z; Ayturk S; Tutuncu NB; Demirag NG
J Natl Med Assoc; 2008 Apr; 100(4):401-5. PubMed ID: 18481478
[TBL] [Abstract][Full Text] [Related]
7. The effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide concentrations.
Manuchehri AM; Jayagopal V; Kilpatrick ES; Atkin SL
Ann Clin Biochem; 2006 May; 43(Pt 3):184-8. PubMed ID: 16704752
[TBL] [Abstract][Full Text] [Related]
8. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
[TBL] [Abstract][Full Text] [Related]
9. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement.
Philippou G; Koutras DA; Piperingos G; Souvatzoglou A; Moulopoulos SD
Clin Endocrinol (Oxf); 1992 Jun; 36(6):573-8. PubMed ID: 1424182
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
Hunt PJ; Richards AM; Nicholls MG; Yandle TG; Doughty RN; Espiner EA
Clin Endocrinol (Oxf); 1997 Sep; 47(3):287-96. PubMed ID: 9373449
[TBL] [Abstract][Full Text] [Related]
11. The effect of altered thyroid function on serum fructosamine concentrations.
Cirillo R; Balzano S; Cossu E; Bartalena L; Solinas MP; Falcone M; Balestrieri A; Martino E
Clin Biochem; 1988 Jun; 21(3):179-81. PubMed ID: 2455610
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.
Faber J; Wiinberg N; Schifter S; Mehlsen J
Eur J Endocrinol; 2001 Oct; 145(4):391-6. PubMed ID: 11580994
[TBL] [Abstract][Full Text] [Related]
13. Correlation between levels of N-terminal pro-B-type natriuretic peptide and degrees of heart failure.
Song BG; Jeon ES; Kim YH; Kang MK; Doh JH; Kim PH; Ahn SJ; Oh HL; Kim HJ; Sung JD; Lee SC; Gwon HC; Kim JS; Kim DK; Lee SH; Hong KP; Park JE; Lee SY; Lee JK
Korean J Intern Med; 2005 Mar; 20(1):26-32. PubMed ID: 15906950
[TBL] [Abstract][Full Text] [Related]
14. N-terminal-pro-B-type natriuretic peptide in acute hyperthyroidism.
Schultz M; Kistorp C; Langdahl B; Raymond I; Hildebrandt P; Faber J
Thyroid; 2007 Mar; 17(3):237-41. PubMed ID: 17381357
[TBL] [Abstract][Full Text] [Related]
15. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects.
Pinkney JH; Goodrick SJ; Katz J; Johnson AB; Lightman SL; Coppack SW; Mohamed-Ali V
Clin Endocrinol (Oxf); 1998 Nov; 49(5):583-8. PubMed ID: 10197072
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
17. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
[TBL] [Abstract][Full Text] [Related]
18. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
[TBL] [Abstract][Full Text] [Related]
19. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
20. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
